Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: ConvaTec Group PLC

Market Cap 5.36B 92.15B 4.62B 4.25B 3.99B 7.49B 506B 7.56B 50.24B 19.63B 248B 20.11B 19.68B 858B P/E Ratio 2026 *
19.5x
P/E Ratio 2027 * 14.8x
Enterprise Value 6.56B 113B 5.65B 5.2B 4.88B 9.16B 620B 9.26B 61.48B 24.01B 303B 24.6B 24.08B 1,050B EV / Sales 2026 *
2.55x
EV / Sales 2027 * 2.33x
Free-Float
95.19%
Yield 2026 *
2.86%
Yield 2027 * 3.21%
1 year 59.76
Extreme 59.76
60.46
3 years 57.13
Extreme 57.13
74.97
5 years 57.13
Extreme 57.13
74.97
10 years 57.13
Extreme 57.13
74.97
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
President 65 01/02/2020
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-.--% - - 5.32B
+0.56%-2.02%-34.62%-15.57% 154B
+0.22%-0.38%-7.90%-8.92% 103B
+1.97%+6.05%+64.78%+55.08% 55.22B
-0.09%+2.68%-4.77%+54.73% 54.8B
-0.49%-2.98%-15.50%-43.19% 40.3B
+1.97%+10.44% - - 30.96B
-1.53%-3.13%-9.48%-43.33% 29.08B
+0.79%+3.65%+49.35%-7.88% 23.23B
-1.27%-3.31%-14.94%-4.50% 20.25B
Average +0.10%+0.63%+3.37%-1.70% 56.71B
Weighted average by Cap. +0.38%-0.11%-5.99%-1.13%

Financials

2026 *2027 *
Net sales 2.57B 44.2B 2.21B 2.04B 1.91B 3.59B 243B 3.63B 24.1B 9.41B 119B 9.64B 9.44B 412B 2.74B 47.18B 2.36B 2.18B 2.04B 3.83B 259B 3.87B 25.72B 10.05B 127B 10.29B 10.08B 439B
Net income 277M 4.76B 239M 220M 206M 387M 26.17B 391M 2.6B 1.01B 12.81B 1.04B 1.02B 44.34B 365M 6.28B 315M 290M 272M 511M 34.52B 516M 3.43B 1.34B 16.9B 1.37B 1.34B 58.5B
Net Debt 1.2B 20.61B 1.03B 950M 891M 1.67B 113B 1.69B 11.23B 4.39B 55.44B 4.5B 4.4B 192B 1.03B 17.7B 887M 817M 766M 1.44B 97.28B 1.45B 9.65B 3.77B 47.64B 3.86B 3.78B 165B
Logo ConvaTec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.741USD
Average target price
4.007USD
Spread / Average Target
+46.16%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!